Study Comparing Ultrasound-guided FICNB Block to Systemic Analgesia in Treatment of Pediatric Femur Fracture

NCT05947292 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2024-07-29

No results posted yet for this study

Summary

The goal of this prospective observational study is to compare pain control strategies in children with femur fractures. Researchers will compare ultrasound-guided fascia iliaca compartment nerve block to IV pain control alone. The main questions it aims to answer are:

* Are ultrasound-guided fascia iliaca compartment nerve blocks as effective as IV pain control in controlling pain?
* Do patients who receive an ultrasound-guided fascia iliaca compartment nerve block require less opioid pain medication than those that don't?

Participants will be asked to provide pain scores during their Emergency Department stay. Participants parents will be asked to complete a brief survey at the time their child is leaving the Emergency Department.

Conditions

  • Femur Fracture

Interventions

PROCEDURE

Ultrasound-Guided Fascia Iliaca Compartment Nerve Block

Patient's who receive this intervention will have an ultrasound-guided fascia iliaca compartment nerve block performed in the Emergency Department.

Sponsors & Collaborators

  • University of Michigan

    collaborator OTHER
  • Medical University of South Carolina

    collaborator OTHER
  • Yale University

    collaborator OTHER
  • Emory University

    collaborator OTHER
  • University of California, San Diego

    collaborator OTHER
  • University of California, San Francisco

    collaborator OTHER
  • Denver Health and Hospital Authority

    collaborator OTHER
  • Children's Hospital of The King's Daughters

    collaborator OTHER
  • Gold Coast Hospital and Health Service

    collaborator OTHER_GOV
  • Zachary Binder

    lead OTHER

Principal Investigators

  • Zachary W Binder, MD · University of Massachusetts, Worcester

Eligibility

Min Age
4 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • United States
  • Australia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05947292 on ClinicalTrials.gov